Maximus Earnings: What To Look For From MMS

Maximus (NYSE: MMS) reports earnings Thursday. The prior quarter revenue was $1.31B, down 4.1% YoY, missing analysts’ revenue expectations, though EPS beat. Full-year revenue guidance slightly missed. For this quarter, consensus expects revenue down 1.6% YoY. Analysts largely reconfirmed estimates; average price target is $105 vs $63.30.

Original reporting
Published Aug 5, 2026, 3:30 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 5, 2026, 4:03 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Maximus Earnings: What To Look For From MMS — source image
Decision brief

The 30-second read

$MMSNeutralMed
01

Why it matters

For traders, the actionable element is the earnings timing plus the consensus expectation of a YoY revenue decline and the company’s recent tendency to miss revenue estimates, which can amplify reaction to any guidance or revenue surprises.

02

Market read

Earnings preview for MMS with consensus revenue decline expectations and peer read-across context, suggesting potential volatility around the Thursday report.

03

What to watch

The article emphasizes revenue misses and consensus reconfirmation but does not detail margin, backlog, contract wins, or guidance specifics that often drive post-earnings repricing.

Relevance 4/10Novelty 4/10Timing: pre-market Thursday earnings release

Background

Maximus is a government services provider reporting earnings this Thursday morning; the article frames the setup using the prior quarter’s revenue miss and current consensus.

Company-level read

Ticker impact

$MMSNeutralMedium confidence
Context

Maximus (MMS) is set to report results Thursday, with the article citing recent revenue miss history and current consensus expectations.

Expected impact

Likely elevated volatility around the earnings release, with direction dependent on whether revenue guidance and EPS beat/miss align with the cited consensus.

Evidence & confidence

The article provides a clear earnings timing catalyst and consensus framing (revenue decline expectation, prior revenue misses), but it does not disclose new company-specific financial results or guidance changes beyond what is already expected.

Market effects

Government and technical consulting peers are referenced (Booz Allen, UL Solutions), implying investors may use peer prints to calibrate read-across expectations for MMS.

None specified.

None specified.

Counterpoint

The stock’s strong recent run-up (up 12.9% over a month) could mean expectations are already elevated, increasing downside risk if revenue guidance disappoints even slightly.

Key entities

  • Maximus

    Subject of the article, scheduled to report earnings Thursday morning; recent quarter included a revenue miss and mixed EPS vs estimates.

  • Booz Allen Hamilton

    Peer cited as having reported Q2 revenue down 4.2% YoY and trading up 8.8% after results.

  • UL Solutions

    Peer cited as having reported Q2 revenue up 5.2% YoY, in line with consensus.

Related articles

$MMSMed

Maximus Q3 Earnings Call Highlights

Maximus (NYSE:MMS) reported Q3 results and guidance on an earnings call. Revised guidance implies adjusted diluted EPS of $1.91 at the midpoint and ~13% adjusted EBITDA margin, with incentive eligibility paused through Dec. 31, 2026. U.S. Federal Services revenue was $721M, U.S. Services $418M, and Outside the U.S. $140M. Total debt was $1.65B, net leverage 2.0x, and it repurchased 750k shares for $50M.

$MMSMed

MAXIMUS, INC. (MMS): Results of Operations and Financial Condition

MAXIMUS, INC. (MMS) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 mms-2026x06x30x8kxex991.htm EX-99.1 Document FOR IMMEDIATE RELEASE CONTACT: James Francis, VP - IR IR@maximus.com Date: August 6, 2026 Maximus Reports Fiscal Year 2026 Third Quarter Results Strong earnings performance reflects disciplined execution (Tysons, Va. - August

$MMSMedAI 8/10

Maximus Cuts FY26 Adj. EPS Outlook; Stock Down 5% - Update

Maximus, Inc. (MMS) reported third-quarter results and cut its FY2026 adjusted EPS outlook to $7.90-$8.20 per share from $8.25-$8.55, citing a temporary contractual change on a major federal program. It kept FY2026 sales guidance at $5.20 billion-$5.35 billion, toward the lower end. Shares were down about 5% premarket to $59.86.

$NVOMedAI 8/10

Novo Nordisk A/S Q2 Earnings Call Highlights

Novo Nordisk reported Q2 adjusted sales of DKK 78.5 billion, with obesity care sales up 16% and GLP-1 diabetes up 2%. Adjusted gross margin fell to 78.2% from 82.7% due to lower prices, about DKK 3 billion one-time manufacturing-cost items, and FX. The company raised 2026 outlook to 0% to -6% adjusted sales and operating profit growth. ZEUS ziltivekimab trial missed its primary endpoint (HR 0.99).

$NYTMed

New York Times Q2 Earnings Call Highlights

The New York Times Company (NYSE:NYT) reported Q2 results on its earnings call. Digital-only subscribers rose 13.3% YoY and digital-only ARPU increased 3.1%. First-half free cash flow was about $266M and the company returned about $160M to shareholders. It guided Q3 digital-only subscription revenue up 12% to 15% and digital ad revenue up mid- to high-teens.